Efficacy of initial triple combination therapy with metformin, dapagliflozin and saxagliptin in drug-naive patients with type 2 diabetes: a randomised controlled trial

被引：0
|
作者：
Kim, N. [1 ]
Kim, J. [2 ]
Moon, J. [3 ]
Lee, Y. -H. [4 ]
Kim, T. [5 ]
Cho, H. [6 ]
Kwak, S. [7 ]
Lim, S. [8 ]
Kim, D. [9 ]
Moon, M. [10 ]
Kim, S. [11 ]
机构：
[1] Korea Univ, Internal Med, Coll Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea
[3] Yeungnam Univ, Coll Med, Daegu, South Korea
[4] Yonsei Univ, Coll Med, Seoul, South Korea
[5] Seoul Med Ctr, Seoul, South Korea
[6] Keimyung Univ, Sch Med, Deagu, South Korea
[7] Seoul Natl Univ Hosp, Seoul, South Korea
[8] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea
[9] Konkuk Univ, Coll Med, Seoul, South Korea
[10] Seoul Natl Univ, Bundang Hosp, Seoul, South Korea
[11] Korea Univ, Coll Med, Seoul, South Korea
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
285
引用
收藏
页码：S151 / S151
页数：1
相关论文
共 50 条
  • [1] Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Lobeglitazone in Drug-Naive Patients with Type 2 Diabetes
    Kim, Kyoung Min
    Lee, Seo Young
    Lee, Ji Hyun
    Lee, Dong Hwa
    Oh, Tae Jung
    Jang, Hak Chul
    Lim, Soo
    [J]. DIABETES, 2017, 66 : A346 - A346
  • [2] Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naive patients with type 2 diabetes: initial triple study
    Lim, Soo
    Ku, Eu Jeong
    Lee, Seo Young
    Lee, Ji Hyun
    Lee, Jie-Eun
    Kim, Kyoung Min
    Davies, Melanie J.
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
  • [3] Efficacy and Tolerability of Initial Triple Combination Therapy with Metformin, Dapagliflozin, and Saxagliptin Compared with Conventional Stepwise Add-on Therapy in Drug-Naive Patients with Type 2 Diabetes-A Randomized, 104-Week, Open-Label, Active-Controlled Trial
    Kim, Nam Hoon
    Kim, Ji Yoon
    Moon, Jun Sung
    Lee, Yong-Ho
    Kwak, Soo Heon
    Lim, Soo
    Moon, Min Kyong
    Kim, Sin Gon
    [J]. DIABETES, 2023, 72
  • [4] Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naive patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial
    Kim, Nam Hoon
    Moon, Jun Sung
    Lee, Yong-ho
    Cho, Ho Chan
    Kwak, Soo Heon
    Lim, Soo
    Moon, Min Kyong
    Kim, Dong-Lim
    Kim, Tae Ho
    Ko, Eunvin
    Lee, Juneyoung
    Kim, Sin Gon
    [J]. DIABETES OBESITY & METABOLISM, 2024, 26 (09): : 3642 - 3652
  • [5] Efficacy and safety of saxagliptin in drug-naive Asian patients with type 2 diabetes mellitus: a randomized controlled trial
    Pan, Chang Yu
    Yang, Wenying
    Tou, Conrad
    Gause-Nilsson, Ingrid
    Zhao, June
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2012, 28 (03) : 268 - 275
  • [6] Initial combination therapy with saxagliptin and metformin improves glycaemic control compared with either monotherapy alone in drug-naive patients with type 2 diabetes
    Chen, R.
    Pfuetzner, A.
    Jadzinsky, M.
    Paz-Pacheco, E.
    Xu, Z.
    Allen, E.
    [J]. DIABETOLOGIA, 2008, 51 : S38 - S38
  • [7] Efficacy and safety of gemigliptin/metformin initial combination therapy versus either as monotherapy in drug-naive patients with type 2 diabetes
    Lim, S.
    Min, K.
    Yu, J. -M.
    Chamnan, P.
    Kim, E.
    Yoon, K. -H.
    Kwon, S.
    Moon, M.
    Lee, K.
    Kim, D. -J.
    Kim, M.
    Wongtanate, M.
    Kim, E.
    Kim, S. -H.
    Lee, M. -K.
    [J]. DIABETOLOGIA, 2015, 58 : S54 - S54
  • [8] Efficacy and tolerability of novel triple combination therapy in drug-naive patients with type 2 diabetes from the TRIPLE-AXEL trial: protocol for an open-label randomised controlled trial
    Kim, Nam Hoon
    Lim, Soo
    Kwak, Soo Heon
    Moon, Min Kyong
    Moon, Jun Sung
    Lee, Yong-ho
    Cho, Ho Chan
    Lee, Juneyoung
    Kim, Sin Gon
    [J]. BMJ OPEN, 2018, 8 (09):
  • [9] Initial Combination Therapy with Metformin Plus Colesevelam in Drug-Naive Hispanic Patients with Early Type 2 Diabetes
    Rosenstock, Julio
    Hernandez-Triana, Eric
    Handelsman, Yehuda
    Misir, Soamnauth
    Jones, Michael R.
    Nagendran, Sukumar
    [J]. POSTGRADUATE MEDICINE, 2012, 124 (04) : 7 - 13
  • [10] Efficacy and safety of linagliptin/metformin fixed-dose combination as initial therapy in drug-naive Asian patients with type 2 diabetes
    Gong, Y.
    Mu, Y.
    Fan, B.
    Hehnke, U.
    Pan, C.
    [J]. DIABETOLOGIA, 2015, 58 : S388 - S388
12345